INTRODUCTION
IN certain communities of young, male adults engaged in strenuous physical training, there has been a considerable amount of acute rheumatism. In a few individuals there was a definite history of some manifestation of rheumatism before admission to the training establishment, but in many the first attack was experienced within a few weeks of entry. The mode of onset was extremely varied. In the majority of cases, nasopharyngeal infection antedated the insidious onset of stiffness and pain in one or more joints which demanded medical attention, and the patient was then found to be febrile. In others, the disease appeared with dramatic onset of hyperpyrexia, sweating and polyarthritis, as in typical rheumatic fever. On the whole, the joint lesions in this latter group of cases have not been striking. Large effusions were not common, but tenderness, slight puffiness and cedema of surrounding tissues, were the usual manifestations. Flitting in character, the joint lesions rapidly improved and left no apparent permanent injury. The initial pyrexia rarely lasted longer than one week irrespective of the treatment adopted, but exceptional cases continued febrile for months. Remissions and relapses occurred frequently and symptoms were greatly relieved by salicylate therapy. Despite the apparent mildness of infection in the early stages of the disease, the cardiac complications have been all too frequent, and have occasioned great anxiety on account of the resulting incapacity. Fortunately, a number of patients did not show any tendency to develop cardiac lesions. As these were otherwise healthy young adults, it was decided that serum, taken from such patients during convalescence, should be tried in the more acute phases of the disease in subsequent cases.
METHOIDS
Preparation of serum.-Patients who were in good general condition about the fourth to eighth week a,fter the temperature had settled were selected for the supply of serum. Other criteria of suitability included the absence of all indications of cardiac complications, and the approach of the erythrocyte sedimentation rate to normal limits. From each patient, 300 c.c. to 400 c.c. blood were obtained, the serum separated, filtered, and preserved by the addition of 0.3% phenol; In this preliminary investigation, the serum from each patient was subjected to the Wassermann reaction and, if negative, was ampouled. Routine sterility tests were performed on each batch of serum.
Do8age. The serum was given either intramuscularly or intravenously in doses of 10 to 20 c.c. Exceptionally larger doses were used as detailed in individual casenotes.
Additional therapy.-As far as possible, no form of treatment other than general nursing and local therapy was used in conjunction with serum. Depending on the preference of the clinician in charge of the case, additional measures such as the use of salicylates, supplemented serum therapy.
RESULTS
Serum has now been uised in the treatment of 15 patients divided into two groups: those treated by serum alone, and the remainder in whom serum therapy supplemented the action of other modes of treatment such as salicylates.
Serum without 8alicylates.-In 10 cases, no salicylates or allied preparations were used throughout the illness. Of these, seven cases, which included six primary attacks and one recurrence, reacted favourably to the treatment. Details of two of these successfully treated cases were as follows 30.11.38: (Chart I) Admitted to hospital, complaining of joint pains in arms and legs. The knee-j oints were both swollen, extremely painful and, in the right knee, there was a considerable effusion. The condition remained unchanged for next five days in absence of any therapy other than careful nursing and local treatment.
6.1.39 to 9.1.39: Intramuscular injection of 10 c.c. convalescent serum given daily. The pains in the joints were greatly eased within a few hours of the first injection, and the patient December Date Decee2 3 4 5 6 7 8 9 10 I 12 13 14 5 6 9 20 21 22 23 24 Section of Therapeutics and Pharmacology 277 passed his first good night on the sixth day of illness. There were no further joint lesions after the ninth day, and the temperature had returned to normal within six days of serum being first given. A mitral systolic murmur was noted on the fifth day of disease but disappeared during the fifth week. Apart from marked bradycardia during the second week, the remainder of convalescence was uneventful. There was no relapse, no evidence of valvular disease on discharge, and the patient has been on duty for several months in apparent good health. -29.8.39 : Admitted to hospital with complaint of pain and swelling of left ankle and, later, right ankle. The right knee was definitely swollen, very tender, and both anklejoints were stiff and sore. Condition remained unchanged on following two days.
31.8.39 to 2.9.39: Intramuscular injection of 10 c.c. convalescent serum given daily. The temperature and pulse-rate progressively fell during next four days and pain was relieved wVithin twenty-four hours. Convalescence was uneventful without any relapse. Finally returned to duty without evidence of cardiac damage.
The five other cases were of this same type: convalescent serum, given in the early stage of the disease, was followed by a rapid fall in temperature, and speedy relief of the symptoms. Six of the seven successfully treated cases were primary attacks, and the seventh was a recurrence. No case has relapsed since treatment and all have returned to duty.
Details of the three cases of this group which did not react favourably to serum therapy were as follows: The remainder of convalescence was uneventful, despite the slow return to normal limits of the erythrocyte sedimentation rate and form'ol-gel reaction. There were no cardiac complications and the patient returned to duty.
Comment.-The first inj-ection of serum had no effect in arresting the disease, and although the second injection was followed by amelioration of symptoms, the chart (not illustrated) indicated that this was a chance association. However, it was noted that there were no further joint manifestations and no cardiac lesions, altho'ugh the sedimentation rate remained abnormal for a further three weeks. He made a steady recovery, the pneumonitis and pericarditis clearing up. A blowing, mitral systolic murmur was heard when the pericardial rub ceased, but this finally disappeared, and he was discharged to duty looking extremely fit. He has now been on duty without relapse.
Two blood cultures during the pyrexial period, and both pericardial and pleural effusions were sterile.
Comment.-Despite the failure of the initial course of serum to prevent the onset of pericarditis, the clinician was of the opinion that the large doses of the second course had a beneficial effect on the complication. Unfortunately, the stock of serum was exhausted. The temperature chart also suggested that the process was temporarily arrested by the serum therapy.
In this group of ten cases, nine have now been at duty for several months without relapse, and with no evidence of permanent cardiac damage. The remaining case probably has a valvular lesion, but tolerance has always been good and he is also back on duty.
Serum and salicylate therapy.-In five cases serum was used during some stage of treatment in combination with or as an alternative to salicylates. Comment.-This case indicated the gravity of the disease and left no doubt as regards the diagnosis. As shown, salicylate therapy alleviated the joint pains but did not prevent the recurrence of arthritic lesions, nor the development of pericarditis. It was interesting to note the continued abnormal erythrocyte sedimentation rate and formol-gel reaction, despite the apparent clinical inactivity of infection over long periods. A disturbing feature of this case was the collapse after the fifth and sixth serum injections. Remainder of convalescence uneventful. Heart apparently escaped damage, and he was discharged fit for duty.
Comment.-Although possibly contributing to the relief of pain, serum had no effect on temperature nor on the general condition. Only a small dosage was used. Comment.-This case illustrated the symptomatic relief given by salicylates without prevention of relapses. In the second relapse colsulanyde was not beneficial. The first serum injection had a slight effect, but the second dose was followed by temporary collapse. This was the second case in which such a phenomenon was encountered.
Three of the five subjects in this second group have returned to duty without carditis. One patient is still convalescent with both mitral and aortic lesions, and one patient has returned to duty with a mitral lesion.
DISCUSSION
This paper records the results of a preliminary investigation on the possible use of convalescent serum in the treatment of acute rheumatism. As the clinical records show, there was a tendency for the initial pyrexia to be of short duration, and this rendered difficult any estimation of the effect of serum on an easily recognized sign. Nevertheless, when given in the early stages of an attack, serum did appear to reduce the period of pyrexia, and this was particularly noticeable in primary attacks. Clinical study of the cases has left no doubt that arthritic pain was relieved in such cases.
Of the 15 cases treated in all, nine were considered to have benefited. Other antisera have been used in the treatment of rheumatism. Thus antistreptococcal serum has been tried with varying success. Wilson (1930) and Hill (1928) reported adversely on its use, while Toogood (1926), Easson and Thomson (1934) , and Small (1928) were of the general opinion that serum was of value.
The volume of serum in the present investigation was not large enough to permit really adequate dosage in every case, but the results obtained justify further extension of the method on the lines suggested.
One point which will require careful investigation, was the occurrence of partial collapse in two individuals within a short period of receiving an injection of serum. The cause of this peculiar phenomenon has not been discovered. Anaphylaxis was considered, but the time relations did not support this possibility. That it was not due simply to repeated dosage has been shown by the absence of any untoward reaction in patients receiving similar courses. Nor could any individual batch of serum be incrinminated since two separate batches were concerned, and other patients treated with the same sera have not been affected. Similar reactions have been reported by Hitchcock, McEwen and Swift (1930) following the use ofantistreptococcal serum and by Poynton and Schlesinger (1937) . In their cases the serum was obtained from heterologous species, whereas in the present series the serum was from the homologous species. Alarming as these two incidents were at the time, they do not present a serious contra-indication as the patients rapidly responded to appropriate treatment.
It is hoped that the investigation will now be extended, and that the true value of serum therapy will be ascertained by its effect on the course of the disease and, in particular, on the prevention of cardiac lesions, when given in adequate doses in the early stages of arthritis.
